"Biotechnologijų projektai", MB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2020 |
|---|
| 83,739 |
| - |
| 1,085 |
| 889 |
| - |
| 29.00 |
| 1.06 |
| 49,200 |
| 13,487 |
| 3,913 |
| 58,774 |
| 2021 |
|---|
| 120,066 |
| - |
| 19,608 |
| 16,650 |
| - |
| 36.37 |
| 13.87 |
| 65,851 |
| 20,438 |
| 3,719 |
| 82,570 |
| 2022 |
|---|
| 102,196 |
| - |
| 16,169 |
| 13,665 |
| - |
| 34.45 |
| 13.37 |
| 79,516 |
| 13,716 |
| 1,604 |
| 91,628 |
Register and
explore Okredo data| 2022 |
|---|
| 102,196 |
| - |
| 16,169 |
| 13,665 |
| - |
| 34.45 |
| 13.37 |
| 79,516 |
| 13,716 |
| 1,604 |
| 91,628 |
Register and
explore Okredo data2022
Turnover (€)
102,196 €
-15 % *
Sales per employee (€)
-Profit before tax (€)
16,169 €-18 % *
Net Profit (€)
13,665 €-18 % *
Profit per employee (€)
-Total profitability (%)
34.45 %-5.28 % *
Net profitability (%)
13.37 %-3.60 % *
Equity (€)
79,516 €
21 % *
Amounts Payable And Liabilities (€)
13,716 €
-33 % *
Non-current Assets (€)
1,604 €-57 % *
CurrentAssets (€)
91,628 €
11 % *